stars 1 stars 2 stars 3

Gadeta B.V. , a Clade Therapeutics Inc. company, is a Research & Development company established in 2015 which focusses on the development of innovative immunotherapies for cancer. The work of the company is based on the groundbreaking discoveries regarding the role of γδ T cell receptors (TCRs) in the broad recognition of both hematological and solid tumor cells and their potential use for the treatment of advanced malignancies as discovered by Prof. Dr. Jürgen Kuball, at the University Medical Centre Utrecht (UMCU), The Netherlands. The Gadeta office and laboratory is located in the Bio Incubator next to the UMCU and collaborates with top-tier international scientists to achieve its goals.

Gadeta Questions

The Gadeta annual revenue was $7 million in 2026.

1 people are employed at Gadeta.

Gadeta is based in Utrecht, Utrecht.

The NAICS codes for Gadeta are [54, 541714, 5417, 54171, 541].

The SIC codes for Gadeta are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users